Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people on Wegovy find themselves suddenly unable to face foods they used to enjoy — not just reduced appetite, but genuine aversion to specific smells, textures or tastes. This is a real, clinically recognised pattern, not a sign that something has gone wrong. Wegovy (semaglutide) slows gastric emptying and acts on appetite-regulating signals in the brain, which can make previously neutral or pleasant foods feel off-putting, particularly during dose increases. Understanding the difference between ordinary appetite suppression and a more specific aversion matters, both for staying well-nourished and for knowing when to flag it to your prescriber. These are prescription-only medicines, and any significant changes to how you're tolerating food are worth discussing with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The misconception most worth correcting here is the idea that strong food aversion is a positive sign, proof the medicine is "doing its job". It isn't. Wegovy is designed to reduce appetite and help you eat less. Aversion to food, particularly when it triggers nausea or stops you eating nutritious meals altogether, is a side effect, not a therapeutic target. Conflating the two can lead people to quietly under-eat, skip meals entirely, or avoid whole food groups for weeks without telling their prescriber. That matters because inadequate protein intake during weight loss accelerates muscle loss, and inadequate food intake alongside nausea increases the risk of dehydration.
Semaglutide acts on GLP-1 receptors both in the gut and in parts of the brain involved in food reward and nausea signalling. That dual action explains why aversions can be oddly specific: many people find they suddenly cannot tolerate greasy or heavily spiced foods, strong-smelling fish, or certain textures like soft fatty meat, even foods they previously ate without a second thought. This is different from simply feeling full sooner. Recognising the distinction is the first step to managing it sensibly. You can read the NHS medicines page for semaglutide for a full breakdown of reported side effects and when to seek help.
Aversions cluster around two moments in particular: starting treatment and stepping up to a higher dose. Each increase in semaglutide dose resets the adaptation process to some extent, so symptoms that had settled may briefly return. For most people, the aversion phase lasts one to two weeks after a dose change before the body adjusts. That's a useful frame to hold onto when a food you normally like suddenly seems impossible, the timing usually maps onto a recent dose increase, and it usually passes.
If you find yourself tracking this, there's a simple habit worth building: when a food aversion flares, note the date and which dose you're on. A quick note in your phone takes under a minute and gives you genuinely useful information, either to reassure yourself that the pattern follows dose changes, or to show your prescriber if it doesn't settle as expected. Persistent aversion that stretches beyond two to three weeks at a stable dose, or that is severe enough to stop you eating balanced meals, warrants a clinical conversation rather than waiting it out alone.
For broader guidance on eating patterns alongside semaglutide, the Wegovy food plan page covers practical approaches to structuring meals when appetite is significantly reduced.
When specific foods have become temporarily unappealing, the practical goal is to protect protein and fluid intake without forcing foods that trigger nausea. Smaller, more frequent portions of whatever is currently tolerable tend to work better than three standard meals. Plain, lower-fat options (eggs, white fish, plain yoghurt, soft cooked vegetables, rice) are easier to tolerate for most people than rich or highly seasoned dishes during a rough patch.
Temperature matters more than people expect. Cold or room-temperature foods often feel less overwhelming than hot ones when nausea is present, because hot food releases more aroma. If a previously favourite meal now smells wrong, trying it cold or at room temperature is worth attempting before writing it off entirely. Some people find that what reads as an aversion to a food is actually an aversion to its smell at a particular temperature, and the cold version is fine.
For specific ideas on what tends to sit well during treatment, our guidance on what to eat while you are on Wegovy is a practical place to start, and the best foods to eat on Wegovy both offer practical starting points. If coffee has become one of the things that now seems unpleasant, you're not alone, there's a dedicated page on coffee aversion on Wegovy that covers why that happens and what helps.
Mild, temporary food aversions during dose adjustment sit within the expected side-effect profile of semaglutide, as described in the NHS guidance. But there are specific signals that should prompt a direct conversation with your prescriber rather than self-management.
Tell your prescriber if: food aversion is severe enough that you're eating less than one small meal a day for more than a day or two; you're showing signs of dehydration (dark urine, dizziness, dry mouth, reduced urination); you've lost the ability to tolerate protein sources across the board; or the aversion is accompanied by persistent vomiting rather than intermittent nausea. Dose reduction or a slower titration schedule is a legitimate clinical option, using the highest dose you can tolerate well is better than pushing through one that's making eating genuinely difficult. A prescriber can also check whether other medicines you take might be contributing.
At nume, every repeat order is reviewed by a GPhC-registered prescriber before dispatch, which is when concerns like persistent food aversion can be raised and addressed. Our Wegovy overview covers the full picture of how treatment is managed from consultation onwards, and our FAQs address many of the day-to-day questions people have once they're on treatment.
If you're not yet on treatment and are weighing up your options, speak to our prescribers, a free consultation reviews your full picture before anything is prescribed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.